Business
CONMED Corporation Adds Kim Kelderman to its Board of Directors
LARGO, Fla., September 09, 2025--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025.
About this update from Conmed Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1518,"height":285,"url":"https://media.zenfs.com/en/business-wire.com/b942da768f0a76f9e8b8398252c8ec36"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/RgKeVOJ9NH3GXxpgD1_yUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b942da768f0a76f9e8b8398252c8ec36","width":960,"height":180},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/1SXptcFzdTHMXCDv8uz7DA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD00NTA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b942da768f0a76f9e8b8398252c8ec36","width":1200,"height":225}},"lazy":false},{"type":"text","content":"LARGO, Fla., September 09, 2025--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025.","length":184,"tagName":"p"},{"type":"text","content":""My fellow directors and I are delighted to welcome Kim to the board," said LaVerne Council, Chair of CONMED’s Board of Directors. "Kim brings extensive global leadership experience across life sciences businesses, with a strong track record in innovation and strategy. Kim’s skills and insights will be valuable additions to the board."","length":357,"tagName":"p"},{"type":"text","content":""Kim is an excellent addition to the board," said Patrick Beyer, President and Chief Executive Officer of CONMED. "We are excited to benefit from his extensive experience and valuable perspective as we pursue our long-term vision and deliver value across our stakeholder community."","length":302,"tagName":"p"},{"type":"text","content":"Mr. Kelderman has been President, Chief Executive Officer, and member of the Board of Bio-Techne (NASDAQ: TECH) since February 2024, having joined Bio-Techne in April 2018, as President, Diagnostics and Genomics, and having served as Chief Operating Officer from November 2023 to January 2024. Prior to Bio-Techne, Mr. Kelderman was employed at Thermo Fisher Scientific where he led three different businesses of increasing scale and complexity. Mr. Kelderman managed the Platforms and Content of the Genetic Sciences Division, where he was responsible for the Instrumentation, Software, Consumables and Assays busi...